Correlation Between Pasithea Therapeutics and Qiagen NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Qiagen NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Qiagen NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Qiagen NV, you can compare the effects of market volatilities on Pasithea Therapeutics and Qiagen NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Qiagen NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Qiagen NV.

Diversification Opportunities for Pasithea Therapeutics and Qiagen NV

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pasithea and Qiagen is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Qiagen NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qiagen NV and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Qiagen NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qiagen NV has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Qiagen NV go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Qiagen NV

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to under-perform the Qiagen NV. In addition to that, Pasithea Therapeutics is 4.11 times more volatile than Qiagen NV. It trades about -0.06 of its total potential returns per unit of risk. Qiagen NV is currently generating about 0.13 per unit of volatility. If you would invest  4,180  in Qiagen NV on August 28, 2024 and sell it today you would earn a total of  145.00  from holding Qiagen NV or generate 3.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy47.62%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  Qiagen NV

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Qiagen NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qiagen NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Qiagen NV is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pasithea Therapeutics and Qiagen NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and Qiagen NV

The main advantage of trading using opposite Pasithea Therapeutics and Qiagen NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Qiagen NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will offset losses from the drop in Qiagen NV's long position.
The idea behind Pasithea Therapeutics Corp and Qiagen NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume